Molybdenum 99 is extracted from highly enriched uranium or low enriched uranium, which is further decayed into Technetium 99. Technetium 99 is extremely useful for medicinal imaging as it emits only gamma rays and can be encapsulated into many different molecules that target various types of tissue in the body. In the current scenario, it is made in nuclear reactors by creating a radioactive isotope of molybdenum, and further decaying it into technetium 99m. The 60-year-old NRU reactor based in Canada is the largest supplier of medicinal isotopes for North America, and the reactor has experienced two extended and unscheduled shutdowns in the past ten years.
Recently, scientists in Canada came up with the medical isotope technetium 99m, which was extracted using medical cyclotrons. This material is made only in a few aging nuclear reactors globally. Cyclotron-based production is pretty compatible, and many medical physicists see it as the future of medical isotopes. It is anticipated that technetium-99m procedures will be replaced by positron-emission tomography, which also uses isotopes made in cyclotrons.
Got questions about your regional growth of
Molybdenum 99 Market?
Just drop us a line or call on +1 646 480 7505
Increasing Demand for Nuclear Medicines to Drive Europe’s Market Growth
Nuclear medicine is progressing well in Europe, and the increasing demand for nuclear medicines is expected to provide a fillip to the molybdenum 99 market growth. Molybdenum 99 is extensively used in the medical imaging industry. During the past ten years, the emerging field of hybrid imaging has contributed immensely to the escalated impact of nuclear medicine on patient management. In 2019, as many as 44.8 million imaging tests were reported in England, compared to 42.7 million in the previous year, showcasing an increase of 4.8%.
Plain radiography (X-Ray) was amongst the most commonly used with almost 23.5 million procedures, followed by diagnostic ultrasonography with 10.2 million. Computerized axial tomography recorded 5.67 million proceedings, and magnetic resonance imaging had 3.74 million proceedings. In Europe, Molybdenum 99 is produced using high enriched uranium.
Molybdenum 99 Market: Segmentation
By Product Type
By Sales Channel
Molybdenum 99 Market: Regions Covered
Central and South America and the Caribbean
The Middle East and Africa
" Crucial Insights The Report Provides:"
* Known and Unknown Adjacencies Influencing the Growth of Market
* Explorable Revenue Sources
* Customer Behaviour Analysis
* Target Partners
* Customized Geographical Data Based on Customers as well as Competitors
* Analysis of Market Size and CAGR between the Forecast PeriodsView Full Report Buy This Report Now